Product Description: Velaprumig is a monoclonal antibody targeting human CD99, CCL25, and anti-human Aβ (Aβ-47F). Velaprumig regulates immune cell migration and reduces β-amyloid-related pathological processes, exerting immunomodulatory and potential anti - Alzheimer's disease activities[1].
Applications: Neuroscience-Neurodegeneration
Formula: N/A
References: [1]World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.
CAS Number: 2988741-17-7
Molecular Weight: N/A
Research Area: Inflammation/Immunology; Neurological Disease
Target: Amyloid-β;CCR